Comments on: Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand https://clinicalvalue.com/cost-utility-of-novel-biomarker-based-strategies-for-hepatocellular-carcinoma-hcc-surveillance-in-thailand/ Tue, 30 Jul 2024 03:53:11 +0000 hourly 1 https://wordpress.org/?v=6.6.2 By: LEAP - Thailand's nationwide HBV screening & EZ Liver Clinic https://clinicalvalue.com/cost-utility-of-novel-biomarker-based-strategies-for-hepatocellular-carcinoma-hcc-surveillance-in-thailand/#comment-6 Tue, 30 Jul 2024 03:53:11 +0000 https://clinicalvalue.com/?p=8722#comment-6 […] – such as blood-based biomarkers, compared to traditional methods like ultrasound – the HECON study evaluated the cost-effectiveness of HCC surveillance in […]

]]>